Buy the Book PDA Download

Update Me E-mail alerts The Merck Manual Minute

Print This Topic Email This Topic

Hashimoto's thyroiditis is chronic autoimmune inflammation of the thyroid with lymphocytic infiltration. Findings include painless thyroid enlargement and symptoms of hypothyroidism. Diagnosis involves demonstration of high titers of thyroid peroxidase antibodies. Lifelong l-thyroxine replacement is typically required.

Hashimoto's thyroiditis is believed to be the most common cause of primary hypothyroidism in North America. It is twice as prevalent in women. Incidence increases with age and in patients with chromosomal disorders, including Down, Turner's, and Klinefelter's syndromes. A family history of thyroid disorders is common.

Hashimoto's thyroiditis, like Graves' disease, is sometimes associated with other autoimmune disorders, including Addison's disease (adrenal insufficiency), type 1 diabetes mellitus, hypoparathyroidism, vitiligo, premature graying of hair, pernicious anemia, connective tissue diseases (eg, RA, SLE, Sjögren's syndrome), and Schmidt's syndrome (Addison's disease, diabetes, and hypothyroidism secondary to Hashimoto's thyroiditis). There may be an increased incidence of thyroid tumors, rarely thyroid lymphoma. Pathologically, there is extensive infiltration of lymphocytes with lymphoid follicles and scarring.

Symptoms and Signs

Patients complain of painless enlargement of the thyroid or fullness in the throat. Examination reveals a nontender goiter that is smooth or nodular, firm, and more rubbery than the normal thyroid. Many patients present with symptoms of hypothyroidism, but some present with hyperthyroidism.

Diagnosis

• Thyroxine (T₄)
• Thyroid-stimulating hormone (TSH)
• Thyroid autoantibodies

Testing consists of measuring T₄, TSH, and thyroid autoantibodies; early in the disease T₄ and TSH levels are normal and there are high levels of thyroid peroxidase antibodies and less commonly of antithyroglobulin antibodies. Thyroid radioactive iodine uptake may be increased, perhaps because of defective iodide organification together with a gland that continues to trap iodine. Patients later develop hypothyroidism with decreased T₄, decreased thyroid radioactive iodine uptake, and increased TSH. Testing for other autoimmune disorders is warranted only when clinical manifestations are present.

Treatment

Occasionally, the hypothyroidism is transient, but most patients require lifelong thyroid hormone replacement, typically l-thyroxine, 75 to 150 μg po once/day.

Last full review/revision June 2008 by Jerome M. Hershman, MD

Content last modified June 2008